Published 3 days ago • loading... • Updated 2 days ago

ESR1 Mutations in ER+/HER2- Advanced Breast Cancer – An Expert Discussion

Summary by European Medical Journal

This episode focuses on the implications of ESR1 mutations in oestrogen receptor-positive (ER+), HER2-negative (HER2-) metastatic breast...

3 Articles

All

Left

Center

Right

Verywell Health

Ask an Expert: What Do Breast Cancer Patients Wish They Knew Before Surgery?

Fact checked by Nick BlackmerFG Trade / Getty ImagesMeet the ExpertMarla Anderson, MD, FACS, is a board-certified surgeon specializing in breast oncology and surgical treatment for breast disease. She serves as Medical Director of Surgical Breast Oncology at the Leonard Cancer Institute at Providence Mission Hospital in Mission Viejo, California.Verywell Health: How do you prepare patients for surgery, what should they know, and what are they of…

2 days ago

Read Full Article

oncnursingnews.com

Evaluating Options for Second-Line HR+, HER2- Breast Cancer Treatment

Katherine Cohen, MSN, FNP-C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment.

2 days ago

Read Full Article